When compared to the current approach of extracting methane gas from organic waste resources and then reforming it into hydrogen, the technology SK ecoplant is developing can cut the time needed for the manufacture of hydrogen by more than 20 times.
Biden tests positive for COVID-19: An infectious disease doctor explains the risks and treatments available for the 79-year-old president
Balenciaga just released its newest creation, but it is getting mixed reactions of disgust and amusement.
Monkeypox is now a national public health emergency in the U.S. – an epidemiologist explains what this means
Tata Motors agreed to purchase Ford Motor's production plant for its own auto manufacturing business.
Starbucks CEO Howard Schultz revealed that they have been working on a very exciting new digital initiative that builds on our existing industry-leading digital platform in innovative ways.
Mykeyring products were created in accordance with official license agreements with license holders.
S. Korean Institute develops AR Technology for breast cancer surgery
The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.